Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.

Mario Sarbia(Pathologie Hamburg-West), H. Gabbert, Michael Ståhl(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), S. Seeber, R. Willers, U. Fink

PubMed

December 1, 1998

Cited by 58

Related Papers

Characterization of the rapamycin-sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis

|Genes & Development|2009|351

Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor

|Journal of Clinical Oncology|2003|259

Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial

|The Lancet. Gastroenterology & hepatology|2020|202

Sch9 regulates ribosome biogenesis via Stb3, Dot6 and Tod6 and the histone deacetylase complex RPD3L

|The EMBO Journal|2011|179

Hsp90 is regulated by a switch point in the C‐terminal domain

|EMBO Reports|2009|173